Lei Meng's most recent trade in Dianthus Therapeutics Inc was a trade of 1,833,333 Pre-Funded Warrants (Right to Buy) done . Disclosure was reported to the exchange on Jan. 22, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Dianthus Therapeutics Inc | Lei Meng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 1,833,333 | 1,833,333 | - | - | Pre-Funded Warrants (Right to Buy) | |
Dianthus Therapeutics Inc | Lei Meng | Director | Grant, award, or other acquisition of securities at price $ 12.00 per share. | 22 Jan 2024 | 1,500,000 | 2,717,554 | - | 12 | 18,000,000 | Common Stock |